Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Foot reflexology or ta-VNS for tinnitus in adults

Official title: Efficacy of Foot Reflexology and Transcutaneous Auricular Vagus Nerve Stimulation on Tinnitus in Non-Cancer Adult Populations

Run by Tzu Chi University · NCT07711639 · Data updated 2026-11-12

This trial tests whether foot reflexology, left-ear vagus nerve stimulation, or auricular acupressure can help reduce tinnitus symptoms in adults with tinnitus.

More Tinnitus trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment180 (estimated)
SponsorTzu Chi University
Academic / other
Locations1 site (Hualien City)
StatusRecruiting
StartedApril 28, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJuly 24, 2026
Trial IDNCT07711639 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with tinnitus as the sole chief complaint and normal audiometric thresholds.

Probably not a fit

Patients with objective tinnitus, certain ear or systemic conditions, or contraindications to the interventions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind, sham-controlled study compares three approaches—foot reflexology, transcutaneous auricular vagus nerve stimulation (ta-VNS), and auricular acupressure—against usual care in adults with tinnitus. Participants are assigned to true or sham subgroups for the reflexology and ta-VNS arms and are followed at baseline, week 2, week 4, and week 8 to measure changes in tinnitus severity, psychological distress, sleep quality, and autonomic indicators. The trial uses a parallel design with repeated measurements and analyzes data using generalized estimating equations. The setting is Hualien Tzu Chi Hospital, with non-cancer adults who have tinnitus as their sole chief complaint and normal hearing thresholds. Outcomes will help determine if these non-pharmacologic interventions can provide meaningful relief for tinnitus-related symptoms.

Why it matters

Potential benefit: If successful, participants could experience reduced tinnitus severity and improved sleep and mood, potentially offering non-drug options for management.

How similar studies have gone: Previous work with ta-VNS and complementary therapies has shown variable benefits; this trial explores a rigorous sham-controlled design to establish value in tinnitus management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-75 years, conscious, able to communicate and comprehend, and able to complete questionnaires and comply with study procedures
* Tinnitus as the sole chief complaint, with pure-tone thresholds ≤25 dB HL bilaterally at 500, 1000, 2000, and 4000 Hz

Exclusion Criteria:

* Objective tinnitus, peripheral vestibular disease, central nervous or cardiovascular causes, or other organic ear pathology
* Open wounds or skin lesions of the foot or ear, lower-limb edema, history of deep vein thrombosis, or diabetes with most recent HbA1c \>7.5%
* Cardiac pacemaker or other implanted electronic device, or other severe cardiovascular disease
* Foot reflexology or vagus nerve stimulation within the past 3 months
* Pregnant or breastfeeding women
* History of epilepsy or seizures
* Physically frail condition

Where it's running

  • Hualien Tzu Chi Hospital, Department of Otorhinolaryngology
    Hualien City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.